Buckle up: Biotech board activist Alex Denner is out to shake things up at Ironwood
The change master of biotech is knocking at Ironwood Pharmaceuticals’ front door. And he wants in with plans to stay for awhile.
Alex Denner, known for forcing out old CEOs and forcing through new buyouts, has now set his sights on the longtime Boston/Cambridge player guided by founding CEO Peter Hecht, who launched the company 20 years ago with a plan for the long haul.
In an unusual move, Ironwood put out word of Denner’s move to join the board in a press release Monday. And the company took the opportunity to pointedly praise the board Hecht has already assembled, which includes 8 independent directors on the 9-member group.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.